- EVIO is a leading provider of cannabis analysis and testing in the U.S.
- Company on track to reach 18 labs by year-end 2018
- Company is guided by strong team of industry and business experts
Operating in one the hottest industries in the marketplace right now, EVIO, Inc. (OTCQB: EVIO) is a life sciences company leading the charge in cannabis analysis and testing. The company currently operates several laboratories throughout the United States—with many more on the horizon—and is a leading provider of accredited cannabis testing, delivering top-quality analytical and consulting services for agricultural and biomedical industries, as well as performing product research. Through its EVIO Labs division, the company offers state-mandated ancillary services to help ensure the quality and safety of the U.S. cannabis supply.
EVIO is on track to open additional labs that will raise its total count to 18 by the end of 2018, and the company has reached this prime position under the guidance of a strong management team composed of business leaders and industry experts.
At the company’s helm are William Waldrop, MBA, and Lori Glauser, BSME, MS/MBA, who cofounded parent company Signal Bay, Inc. and have guided EVIO from its foundations as a startup advisory firm in 2014 to its current nationwide presence.
Serving as the CEO and board chairman for EVIO, Waldrop obtained a Bachelor of Science degree from California State University-Long Beach and an MBA in finance from the University of Southern California. In 2014, he formed EVIO as a public company, and, in 2015, he oversaw the acquisition of EVIO’s first analytical laboratory. In past corporate incarnations, Waldrop served as board chairman and CEO of Newport Entertainment Group, president and COO of College Partnership, senior manager at AirTouch Cellular and vice president of operations for Leading Edge Broadband.
Also a driving force behind EVIO’s success, Glauser oversees strategic growth and day-to-day operations for the company. She additionally leads EVIO’s advisory services division. Glauser has a Bachelor of Science in mechanical engineering from the University of New Hampshire and an MBA from the University of Alabama. She is the founding chair of Women Grow-Las Vegas, has served on the FOCUS standards committee, is the coauthor of ‘Medical Marijuana Desk Reference’ and speaks frequently at cannabis industry conferences. Glauser has a 25-year background in engineering, management, consulting and startups, with expertise in business planning and operations, business process design, financial forecasting, risk, customer experience, and regulatory policy. She formerly served as a management consultant focusing on the energy industry, working with leading firms like Ernst & Young, IBM, Financial Times Group and SNL Financial.
In addition, guiding the EVIO team are chief science officer and Director Anthony Smith, Ph.D.; President Al Lustig, MBA; Evio Oregon Director and President Henry Grimmett, BS, MA; EVIO Labs Berkeley Laboratory Director Tobias Paquet, BS; EVIO Labs Colorado Laboratory Director Stephen Goldman, BS, MS; EVIO Labs Eugene Vice President of Sales Michael Lausmann; EVIO Labs California General Manager Catherine Emond, MS, MA; and EVIO Labs Eugene Vice President of Client Relations Sara Lausmann, BA.
For more information, visit the company’s website at www.EVIOLabs.com
More from CannabisNewsWire
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
